Zogenix

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

You can watch Zogenix and buy or sell other stocks, options, and ETFs commission-free!

About ZGNX

At Zogenix, our core strategy is to develop and commercialize differentiated central nervous system (CNS) and pain therapeutics that can address significant unmet medical needs or overcome limitations of existing products. We are a specialty pharmaceutical company with two proprietary product candidates in late-stage development for the treatment of central nervous system disorders and pain. 

CEO
Stephen James Farr, PhD
CEOStephen James Farr, PhD
Employees
327
Employees327
Headquarters
Emeryville, California
HeadquartersEmeryville, California
Founded
2006
Founded2006
Employees
327
Employees327

ZGNX Key Statistics

Market cap
1.50B
Market cap1.50B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
3.46M
Average volume3.46M
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$26.90
52 Week high$26.90
52 Week low
$11.03
52 Week low$11.03

ZGNX Earnings

-$1.05
-$0.70
-$0.35
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 3, After Hours
ActualExpected Nov 3, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.